In addition, Hallén et al [ 22 ] have recently found in a relatively young and healthy type 2 diabetic population elevations of cardiac troponin with a clear trend toward adverse outcomes.
← all excerpts
Prevalence and risk factors accounting for true silent myocardial ischemia: a pilot case-control study comparing type 2 diabetic with non-diabetic control subjects.
1
—
—